dbo:abstract |
Camrelizumab (SHR-1210) (INN) is an anti-PD-1 immune checkpoint inhibitor that is being investigated for hepatocellular carcinoma and Hodgkin lymphoma. This drug is being developed by Jiangsu HengRui Medicine Co., Ltd. As of 2019, camrelizumab is undergoing Phase II/III trials. (en) 卡瑞利珠单抗 (Camrelizumab,研发代号SHR-1210,商品名艾瑞卡)( INN )是一种抗PD-1免疫检查点抑制剂,正在针对肝细胞癌的适应症进行多国临床试验。 该药物由江苏恒瑞医药有限公司开发,2019年起该药在多国接受Ⅱ/Ⅲ期临床试验。2019年底该药在中国上市。 (zh) |
dbo:casNumber |
1798286-48-2 |
dbo:fdaUniiCode |
73096E137E |
dbo:wikiPageID |
58570082 (xsd:integer) |
dbo:wikiPageLength |
2443 (xsd:nonNegativeInteger) |
dbo:wikiPageRevisionID |
1084702516 (xsd:integer) |
dbo:wikiPageWikiLink |
dbr:Phase_III_clinical_trial dbr:Programmed_cell_death_1 dbr:Checkpoint_inhibitor dbr:Hepatocellular_carcinoma dbr:International_Nonproprietary_Name dbc:Monoclonal_antibodies dbr:Hodgkin_lymphoma dbr:Phase_II_clinical_trial |
dbp:atcPrefix |
none (en) |
dbp:casNumber |
1798286 (xsd:integer) |
dbp:mabType |
mab (en) |
dbp:source |
zu (en) |
dbp:synonyms |
SHR-1210 (en) |
dbp:target |
dbr:Programmed_cell_death_1 |
dbp:type |
mab (en) |
dbp:unii |
9223372036854775807 (xsd:decimal) |
dbp:wikiPageUsesTemplate |
dbt:As_of dbt:Infobox_drug dbt:Reflist dbt:Short_description dbt:Fdacite dbt:Monoclonals_for_immune_system dbt:Monoclonal-antibody-stub |
dcterms:subject |
dbc:Monoclonal_antibodies |
rdf:type |
owl:Thing dul:ChemicalObject dbo:ChemicalSubstance wikidata:Q8386 dbo:MonoclonalAntibody dbo:Drug |
rdfs:comment |
Camrelizumab (SHR-1210) (INN) is an anti-PD-1 immune checkpoint inhibitor that is being investigated for hepatocellular carcinoma and Hodgkin lymphoma. This drug is being developed by Jiangsu HengRui Medicine Co., Ltd. As of 2019, camrelizumab is undergoing Phase II/III trials. (en) 卡瑞利珠单抗 (Camrelizumab,研发代号SHR-1210,商品名艾瑞卡)( INN )是一种抗PD-1免疫检查点抑制剂,正在针对肝细胞癌的适应症进行多国临床试验。 该药物由江苏恒瑞医药有限公司开发,2019年起该药在多国接受Ⅱ/Ⅲ期临床试验。2019年底该药在中国上市。 (zh) |
rdfs:label |
Camrelizumab (en) 卡瑞利珠单抗 (zh) |
owl:sameAs |
wikidata:Camrelizumab dbpedia-zh:Camrelizumab https://global.dbpedia.org/id/9M4R2 |
prov:wasDerivedFrom |
wikipedia-en:Camrelizumab?oldid=1084702516&ns=0 |
foaf:isPrimaryTopicOf |
wikipedia-en:Camrelizumab |
is dbo:wikiPageWikiLink of |
dbr:Jiangsu_Hengrui_Medicine dbr:List_of_therapeutic_monoclonal_antibodies |
is foaf:primaryTopic of |
wikipedia-en:Camrelizumab |